Page 150 - Liver Diseases in Children
P. 150

140      โรคตับในเด็ก




              pthaigastro.org
            16.  Shah KK, O’Dell SD.  Effect of dietary interventions in the maintenance of normoglycaemia in glycogen
               storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet 2013;26:329-39.
            17.  Bhattacharya K.  Dietary dilemmas in the management of glycogen storage disease type I. J Inherit

               Metab Dis 2011;34:621-9.
            18.  Wang DQ, Fiske LM, Carreras CT, Weinstein DA.  Natural history of hepatocellular adenoma formation
               in glycogen storage disease type I. J Pediatr 2011;159:442-6.
            19.  Beegle RD, Brown LM, Weinstein DA.  Regression of hepatocellular adenomas with strict dietary
               therapy in patients with glycogen storage disease type I. JIMD Rep 2015;18:23-32.
            20.  Minarich LA, Kirpich A, Fiske LM, Weinstein DA.  Bone mineral density in glycogen storage disease type
               Ia and Ib. Genet Med 2012.
            21.  Boers SJ, Visser G, Smit PG, Fuchs SA.  Liver transplantation in glycogen storage disease type I.
               Orphanet J Rare Dis 2014;9:47.
            22.  McKiernan PJ. The acutely ill baby. In: Kelly DA, editor. Diseases of the liver and biliary system in
               children. 4th ed. West Sussex: John Wiley & Sons Ltd; 2017. p. 127-43.

            23.  Demirbas D, Brucker WJ, Berry GT.  Inborn errors of metabolism with hepatopathy: metabolism defects
               of galactose, fructose, and tyrosine. Pediatr Clin North Am 2018;65:337-52.
            24.  Bosch AM.  Classical galactosaemia revisited. J Inherit Metab Dis 2006;29:516-25.
            25.  Parenti G, Andria G, Ballabio A.  Lysosomal storage diseases: from pathophysiology to therapy. Annu
               Rev Med 2015;66:471-86.
            26.  Pastores GM, Hughes DA.  Non-neuronopathic lysosomal storage disorders: disease spectrum and
               treatments. Best Pract Res Clin Endocrinol Metab 2015;29:173-82.
            27.  Desnick RJ, Schuchman EH.  Enzyme replacement therapy for lysosomal diseases: lessons from
               20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet 2012;13:307-35.
            28.  Hartley J. The jaundiced baby. In: Kelly DA, editor. Diseases of the liver and biliary system in children.
               4th ed. West Sussex: John Wiley & Sons Ltd; 2017. p. 99-126.
            29.  Scott K, Gadomski T, Kozicz T, Morava E.  Congenital disorders of glycosylation: new defects and still
               counting. J Inherit Metab Dis 2014;37:609-17.
            30.  Rahman S.  Gastrointestinal and hepatic manifestations of mitochondrial disorders. J Inherit Metab Dis
               2013;36:659-73.

            31.  Fellman V, Kotarsky H.  Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med
               2011;16:222-8.
            32.  Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, et al.  Use of whole-exome sequencing to
               determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA
               2014;312:68-77.
            33.  Wong LJ, Scaglia F, Graham BH, Craigen WJ.  Current molecular diagnostic algorithm for mitochondrial
               disorders. Mol Genet Metab 2010;100:111-7.
   145   146   147   148   149   150   151   152   153   154   155